Literature DB >> 25073243

Hepatic adenomatosis: MR imaging features.

I De Kock, K J Mortelé, B Smet, P Gillardin, W Pauwels, A I De Backer.   

Abstract

Hepatocellular adenomas are rare benign liver neoplasms that commonly occur in women with a history of oral contraceptives intake for more than 2 years. Hepatic adenomatosis is characterized by the presence of multiple adenomas, arbitrarily > than 10, involving both lobes of the liver, without any history of steroid therapy or glycogen storage disease. Although the adenomas in liver adenomatosis are histologically similar to other adenomas, liver adenomatosis appears to be a separate clinical entity. Adenomas in hepatic adenomatosis may be of the inflammatory, hepatocyte nuclear factor 1alpha-mutated, or beta-catenin-mutated subtype, and accordingly show variable imaging appearances. Hepatic adenomatosis carries the risk of impaired liver function, hemorrhage and malignant degeneration. We report a case with the inflammatory subtype of hepatic adenomatosis in a 39-year-old woman with liver steatosis. The magnetic resonance imaging features using extracellular gadolinium chelates and hepatocyte-targeted contrast agents are described.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25073243     DOI: 10.5334/jbr-btr.25

Source DB:  PubMed          Journal:  JBR-BTR        ISSN: 0302-7430


  3 in total

1.  Long-term follow-up of hepatic adenoma and adenomatosis: analysis of size change on imaging with histopathological correlation.

Authors:  N Shao; A Pandey; M A Ghasabeh; P Khoshpouri; P Pandey; F N Varzaneh; M Zarghampour; D Fouladi; T M Pawlik; R A Anders; I R Kamel
Journal:  Clin Radiol       Date:  2018-07-18       Impact factor: 2.350

Review 2.  Current Approaches in the Management of Hepatic Adenomas.

Authors:  Diamantis I Tsilimigras; Amir A Rahnemai-Azar; Ioannis Ntanasis-Stathopoulos; Maria Gavriatopoulou; Demetrios Moris; Eleftherios Spartalis; Jordan M Cloyd; Sharon M Weber; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-08-14       Impact factor: 3.452

3.  Management and outcome of hepatocellular adenoma with massive bleeding at presentation.

Authors:  Anne J Klompenhouwer; Robert A de Man; Maarten Gj Thomeer; Jan Nm Ijzermans
Journal:  World J Gastroenterol       Date:  2017-07-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.